Bringing our research and experience to your personalized care:

Allelium™ origin story began in the late 1990s, with Pine Street Clinic’s first clinical application of genomically targeted herbal and lifestyle medicine in support of the health of persons with cancer.  Two early examples of the integrative approach involved Herceptin for HER2-positive breast cancer and Gleevec targeting the BCR-ABL fusion protein. Today there are more than 60 “companion diagnostics” approved by the FDA and most of these are in oncology using immunohistochemistry (IHC), polymerase chain reaction (PCR) and next generation sequencing (NGS).   Collectively, these technologies provide a strong data-driven support for further individualizing care using integrative natural compound and lifestyle interventions, and inspired us to make this clinical decision support tool available for you.

Allelium™ is at the forefront of integrative “high-definition medicine” (*hdMED). This is made possible by technological advances allowing highly detailed assessments and management of our health bringing together DNA sequencing, physiological and environmental monitoring and behavioral tracking.

Clinicians and patients want and expect the landscape of healthcare to continually evolve, bringing enhanced patient outcomes. Allelium™ combines advanced technologies that strengthen and further personalize strategies from the broad domain of healing resources based on what we are calling “full spectrum medicine” (*FSM).

Each patient is unique and their treatment should be tailored accordingly. Allelium™ brings personalized medicine, where genomic profiling is integrated with a complete set of full spectrum medicine’s diagnostics and interventions. This combination  deepens insights into imbalances that may not be evident through conventional medical tests alone. The clinical union of everything that represents the technology of western scientific medicine  plus “everything else”, allows a more comprehensive understanding of a patient’s health story.